semaglutide 1.75 mg Wegovy is a glucagon Ozempic® (semaglutide) injection 0.5 mg,

No Membership Fees No Insurance Required

And it delivers: 16.7% average weight loss in 12 months Achieved using 66% less GLP-1 medication than industry norms 8 out of 10 members transition off meds without regaining weight That means lower total cost of care, reduced long-term pharmacy spend, fewer relapses and yo-yo dieting, and better employee satisfaction and retention

Pacesa, M., Palea, O

That is exactly why protein must be the foundation of every meal, not an afterthought

The STEP 1 trial (N=1,961) demonstrated that semaglutide 2.4 mg produced 14.9% mean body weight reduction at 68 weeks versus 2.4% with placebo [7]

What are your payment terms